CD8A and systemic sclerosis: In a study by Fuschiotti and colleagues (2009) [40], effector CD8+ T cells were found to be more frequent in SSc patients, although other studies have shown either no difference or decreased levels of both T cell subtypes in SSc patients as compared to HVs [39].